Doenças autoimunes do sistema nervoso
Palavras-chave:
autoanticorpo, doenças autoimunes, miastenia gravis, neuropatia inflamatória, esclerose múltiplaResumo
A evolução recente do conhecimento no campo das doenças do sistema nervoso mediadas imunologicamente tem trazido novas prespectivas nos aspectos de diagnóstico e tratamento. Paralelamente, um melhor conhecimento das especificidades moleculares dos autoanticorpos envolvidos tem também sido possível. Este trabalho pretende rever alguns conceitos actuais nesta área.
Downloads
Referências
Drachman D. Myasthenia Gravis. ln J sselbacher, Braunwald, Wilson, Martin, Fauci, Kasper, eds, Harrison's Principies of Internai Medicine, 13th edition, pp 2393-2396, McGraw-Hill, Inc, 1994.
Oostherhuis H, Kuks J. Myasthenia Gravis and Myasthenic Syndromes. Curr Opin Neurol Neurosurg 1992; 5: 638-644.
Eymard B, Berrih AS. Rôle du Timus dans la Physiopathologie de la Myasthenie. Rev Neurol 1995; 151: 6-15.
Sreck A. Antibodies in the Neurology Clinic. Neurology 1990; 40: 1489-1492.
Kuks J, Limburg P, Horst G, et al. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part 1. Diagnostic Value for the Detection of Timoma . J Neurol Sci 1993; 119: 183-188.
Kuks J, Limburg P, f-Jorst G, Oostherhuis H. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part 2. Prevalence in non Thymoma Patients. J Neurol Sci 1993; 120: 78-81.
Kuks J, Limburg P, Horst G, Oostherhuis H. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part 3. Relation With Clinical Course and Therapy. J Neurol Sci 1993; 120: 168-173.
Steck A: lnflammatory Neuropathy. Pathogenesis and Clinical Features. Curr Opin Neurol Neurosurg 1992; 5: 633-637.
Steck A, Kappos L. Gangliosides and Autoimmune Neuropathies. Classification and Clinical Aspects of Autoimmune Neuropathies. J Neur Neurosurg Psych 1994; (Suppl.) 57: 26-28.
llyas A, Mithen F, Chen Z, Cook S. Search for Antibodies to Neural Glycolipids in Séra of Patients with Guillain-Barré Syndrome. J Neuroç Sci 1991; 102: 67-75.
Fredman P, Vedeler C, Nyland H, et al. Antibodies in Sera from Patients with lnflammatory Demyelinating l'olyradiculoneuropathy React with Ganglioside LMl and Sulphatide of Peripheral Nerve Myelin. J Neural 1991 ; 238 75-79.
Simone I, Annunziata P, Maimone D, et al. Serum and CSF anti-GMJ antibodies in Patients with Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy. J Neural Sei 1993; 114: 49-55
Steck A, Murray N, Dellagi K, et al. Peripheral Neuropathy Associated with Monoclonal lgM Autoantibody. Ann Neurol 1987; 22: 764-767.
Hauser S. Multiple Sclerosis and other Demyelinaring Diseases. ln Jsselbacher, Braunwald, Wilson, Maltin, Fauci, Kasper, eds, Harrison's Principies of Internal Medicine, 13th edition, pp 2287-2295, McGraw-Hill, Jnc, 1994
Olsson T. Immunology of Multi pie Sclerosis. Curr Opin Neural Neurosurg 1992; 5: 195-202.
Ransohoff R, Tuohy V, Lehmann P. The Immunology oi Multi pie Sclerosis: New lntricacies and New lnsights. Curr Opin Neural 1994; 7: 242-249
Hohlfeld R, Meinl E, Weber F, et al. The Role of Autoimmune T Lymphocytes in the Pathogenesis of Multiple Sclerosis. Neu rology 1995; 45 (suppl 6): S33-S38.
Warren K, Catz I, Johnson E, Mielke B. Anti-Myelin Basic Protein and Anti-Proteolipid Protein Specific Fonns of Multiple Sclerosis. Ann Neurol 1994; :35: 280-289.
Faulds D, Benfield P. lnterferon beta-ib in Multiple Sclerosis. An lnitial Review of its Rational Use and Therapeutic Potential. Clin Immunother 1994; 1: 79-87.
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
